J&J sued over Levaquin side effects; 'Viva Viagra' missile man loses suit;

> Twenty plaintiffs have sued Johnson & Johnson and Walgreen over Levaquin, a fluoroquinolone antibiotic that has been linked to tendinitis and tendon rupture. Article

> A U.S. judge ruled that Pfizer's trademark had been infringed when a man towed a decommissioned missile around Manhattan emblazoned with the words "Viva Viagra," the slogan for Pfizer's blockbuster impotence drug. Article

> Phoenix Chemicals has bought a Scottish Shasun Pharma Solutions plant and says it may rehire some of the 80 employees laid off when the facility closed. Article

> Merck got the nod from European regulators for restricted first-line use of its diabetes treatment Januvia. Article

> Ista Pharmaceuticals won FDA approval for its Bepreve drop for itchy eyes from allergies. Article

> Care-Tech Laboratories agreed to pull antimicrobial drugs off shelves after the FDA said the products aren't approved for their intended use. Article

> German drug and chemical maker Merck KGaA bought Chinese pigment company Suzhou Taizhu Technology Development in a deal that gives it more clout in a fast-growing market. Article

Biotech News

> Shares of Opexa Therapeutics more than doubled this morning after the developer announced that 83 percent of all patients taking its therapeutic vaccine for multiple sclerosis had remained relapse-free for a year. Article

> In a major setback, Osiris Therapeutics announced this morning that preliminary results indicate that its stem cell therapy Prochymal failed both of its late-stage clinical trials. One analyst swiftly dubbed the preliminary results "horrible," and shares of the company swiftly plunged 52 percent. Article

> Headed into the long weekend last Friday, Biogen Idec unveiled a $356 million bid to buy Facet Biotech, which had already turned a cold shoulder to an earlier, and higher, offer last August. Article

Manufacturing News

> United Therapeutics has pulled out all the green stops in its recently completed facility in Research Triangle Park, NC. The hub-and-spoke building houses manufacturing at the core with R&D and administrative functions as spokes. Article

> GMP expert Lachman Consultants is overseeing production re-start at embattled specialty drug maker KV Pharmaceutical, which is preparing for an FDA inspection required before it can resume product shipments. Article

> Amsterdam-based SynCo Bio Partners has expanded its reach to Japan, where it will manufacture a live biotherapeutic for an emerging Japanese pharmaceutical company. Article

> Five strategies based on industry best practices can help pharma manufacturers improve forecast accuracy and manufacturing planning. Article

And Finally... A simple blood test may help doctors determine which patients need antibiotics, offering a way to combat overuse of the drugs. Article

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.